CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled / 12 target
Drug / intervention
3D-Ultrasound-Guided Transperineal Microwave needle ablation of BPHdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05443451
NCT05443451N/ACompletedOn Track (0.3/mo)Completion was 32mo ago

3D-Ultrasound-Guided Transperineal Microwave Needle Ablation for Men With Symptomatic Benign Prostatic Hyperplasia

Chinese University of Hong Kong·interventional·Posted Jul 5, 2022·Updated Jun 23, 2026

In Brief

A clinical study evaluating 3D-Ultrasound-Guided Transperineal Microwave needle ablation of BPH for Prostate Hyperplasia. Completed, enrolled 12 participants across 1 site.

Detailed Summary

This is a pilot study on applying 3D-Ultrasound-Guided Transperineal Microwave needle ablation for men with symptomatic benign prostatic hyperplasia (BPH).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesHong Kong
CollaboratorsKoelis

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 5, 2022
Enrollment StartSep 8, 2022
Primary CompletionOct 5, 2023
Study CompletionOct 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 4.0 years ago

Arms & Interventions

Transperineal Microwave needle ablation for symptomatic BPHexperimental

Device: 3D-Ultrasound-Guided Transperineal Microwave needle ablation of BPH

Interventions

3D-Ultrasound-Guided Transperineal Microwave needle ablation of BPHdevice

The procedure will consist of a focal, transperineal, targeted microwave ablation of prostate adenoma. Surgical planning using 3D transrectal ultrasound and real-time monitoring of the ablation would preserve key anatomical landmarks such as the bladder neck, prostatic urethra and verumontanum. The Organ-Based Tracking (OBT®) patented technology would provide a 3D prostate model to facilitate real-time navigation-guided ablation and accurate mapping of treatment zone. The procedure will be conducted under general anaesthesia, spinal anaesthesia, or monitored anaesthetic care / sedation. An average number of one to three microwave ablations per lobe is expected, depending on the size and shape of each prostate. The microwave ablation parameters will be chosen intraoperatively. A urinary catheter may be necessary immediately after the procedure. Patients are planned to be discharged on the same day or the day after when they are fit for discharge.